メインコンテンツにスキップ
検索

薬事戦略

登録

最新のリソース

注目コンテンツ

Upcoming strategic leadership webinars

Popular resources

以下のイベントで弊社のエキスパートをご紹介

All Strategic Leadership resources

Investor panel: What it takes to build a fundable biotech – with Life Science Nation

Certara Services, Drug Development, Webinar

Important drug development questions that model-based meta-analysis answers

Certara Services, Clinical Pharmacology, Drug Development Support, Model Informed Drug Development, Modeling and Simulation - MBMA, Blog

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Publication

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Conference

リアルワールドエビデンスを活用した妊娠研究における臨床試験の強化

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Real World Evidence, Therapeutic Specialties, Blog

IND申請と資金調達に向けた開発プログラムの構築

Certara Services, Clinical Pharmacology, Drug Development, Modeling and Simulation, New Approach Methodologies (NAMs), On-Demand Webinar

Beyond compliance: What ICH M15 means for the future of drug development

Certara Services, Clinical Pharmacology, Drug Development, ICH M15, Model Informed Drug Development, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog

Certainty US 2026 recap: Advancing model-informed drug development right from the start

AI & Machine Learning, Data Standards, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog

Integrated Population Pharmacokinetic, Pharmacodynamic, and Safety Analyses to Inform Dosage Selection in the Clinical Development of the ATR Inhibitor Tuvusertib

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication

Data fabrics in pharma: Connecting data for better decisions

AI & Machine Learning, Certara Products, Certara.AI, Drug Development, Blog

Regulatory horizons 2026: Clinical pharmacology strategy and regulatory expectations

Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, New Approach Methodologies (NAMs), Blog

モデルに基づく医薬品開発（MIDD）を通じたファーマコエクイティの推進：ASCPT 2026からのインサイト

Certara Services, Clinical Pharmacology, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog
ニュースレターを購読

今すぐ登録：医薬品開発の革新は、サターラの情熱そのものです。最新情報を入手し、ともに科学の限界を切り拓いていきましょう。


Powered by Translations.com GlobalLink Web Software